Construction of RNAi Targeting CLU Gene and Effect of CLU on Biological Function of Nasopharyngeal Cancer Cells
-
摘要:目的
构建CLU基因干扰重组质粒及建立CLU基因干扰转染鼻咽癌细胞及动物模型，检测CLU对鼻咽癌细胞生物学功能的影响。
方法首先以real-time PCR和Western blot法验证CLU在鼻咽癌细胞系5-8F，6-10B中的表达，以高表达CLU的5-8F细胞作为干扰转染的目标细胞；设计及构建shRNA表达载体pSR-GFP/Neo-CLU-shRNA，将其转染至5-8F鼻咽癌细胞系中，通过Transwell小室迁移及侵袭实验来检测对其迁移和侵袭功能的影响。
结果与6-10B细胞比较，CLU基因在5-8F中的表达显著上调（P<0.05）；干扰鼻咽癌细胞5-8F中的CLU可使细胞迁移和侵袭功能明显减弱（P<0.05），使其体外成瘤能力显著降低（P<0.05）。
结论CLU基因在鼻咽癌细胞系5-8F中明显高表达；pSR-GFP/Neo-CLUshRNA可成功干扰5-8F中CLU的表达；CLU可抑制5-8F细胞的迁移、侵袭及体内成瘤能力。
Abstract:ObjectiveTo construct the RNAi targeting Clusterin (CLU) gene, to explore the effect of interference targeting CLU on the biological behavior of nasopharyngeal carcinoma (NPC) cells.
MethodsWe detected the expression of CLU in NPC cell lines 6-10B and 5-8F through the real-time PCR and Western blot; then we constructed pSR-GFP/Neo-CLU-shRNA expression vector targeting CLU. Based on interference targeting CLU on NPC, we tested the cell migration and motility by Transwell migration and motility assay.
ResultsThe expression of CLU was increased in NPC cell line 5-8F compared with NPC cell line 6-10B (P<0.05) . When the gene CLU of 5-8F was interfered, the cell migration, invasion and tumorigenicity were weakened.
ConclusionThe expression of CLU is up-regulated in NPC cell line 5-8F. pSR-GFP/Neo- CLU-shRNA could successfully inhibit the expression of CLU in NPC cell line 5-8F. CLU could inhibit the migration, invasion and tumorigenicity of 5-8F cells in vivo.
-
Key words:
- Nasopharyngeal cancer(NPC) /
- CLU /
- Neoplasm metastasis
-
-
![]()
图 1 QRT-PCR法分析CLU-mRNA在6-10B和5-8F细胞系中的表达
Figure 1 Expression of CLU-mRNA in NPC cell lines 6-10B and 5-8F determined by QRT-PCR
![]()
图 2 Western blot法检测不同鼻咽癌细胞系中CLU蛋白表达水平
Figure 2 Protein expression of CLU in NPC cell lines detected by Western blot
![]()
图 3 Western blot法检测干扰转染后CLU蛋白表达
Figure 3 Protein expression of CLU detected by Western blot after interference
![]()
图 4 CLU-shRNA对5-8F细胞侵袭及迁移能力的影响
Figure 4 Effect of CLU-shRNA on invasion and migration of 5-8F cells
-
[1] Wei W I, Sham J S . Nasopharyngeal carcinoma[J]. Lancet, 2005, 36 5(9476): 2041-54. [1] Wei W I, Sham J S . Nasopharyngeal carcinoma[J]. Lancet, 2005, 365(9476) : 2041-54.
[2] Wang X, Li L, Hu C, et al. Patterns of level Ⅱ node metastasis in nasopharyngeal carcinoma[J]. Radiother Oncol, 2008, 89(1): 28 -32. [2] Wang X, Li L, Hu C, et al. Patterns of level Ⅱ node metastasis in nasopharyngeal carcinoma[J]. Radiother Oncol, 2008, 89(1) : 28-32.
[3] Zhao Y, Wang Y, Zeng S, et al. Lmp1 expression is positively associated with metastasis of nasopharyngeal carcinoma: Evidence from a Meta-analysis[J]. J Clin Pathol, 2012, 65(1) : 41-5.
[3] Zhao Y, Wang Y, Zeng S, et al. Lmp1 expression is positively associated with metastasis of nasopharyngeal carcinoma: Evidence from a Meta-analysis[J]. J Clin Pathol, 2012, 65(1): 41-5. [4] 刘文斌, 罗非君, 曹亚. Eb病毒编码的潜伏膜蛋白1参与鼻咽癌侵袭和转移的研究进展[J]. 国际病理科学与临床杂志, 2010, 30(6) : 484-8. Liu WB, Luo FJ, CAO Y. Latest advances in the study on the involvement Epstein-Barr virus encoded latentmembrane protein 1 in nasopharyngeal carcinoma invasion andmetastasis[J]. Guo Ji Bing Li Ke Xue Yu Lin Chuang Za Zhi, 2010, 30(6) : 484-8.
[4] Liu WB, Luo FJ, CAO Y. Latest advances in the study on the involvement Epstein-Barr virus encoded latentmembrane protein 1 in nasopharyngeal carcinoma invasion andmetastasis[J]. Guo Ji Bing Li Ke Xue Yu Lin Chuang Za Zhi, 2010, 30(6): 484-8. [刘文斌, 罗非君, 曹亚. Eb病毒编码的潜伏膜蛋白1参与鼻咽癌侵袭和转 移的研究进展[J]. 国际病理科学与临床杂志, 2010, 30(6): 484-8.] [5] Fotheringham JA, Raab-Traub N. Epstein-barr virus latent membrane protein 2 effects on epithelial acini development reveal distinct requirements for the PY and YEEA motifs[J]. J Virol, 20 13, 87(24): 13803-15. [5] Fotheringham JA, Raab-Traub N. Epstein-barr virus latent membrane protein 2 effects on epithelial acini development reveal distinct requirements for the PY and YEEA motifs[J]. J Virol, 2013, 87(24) : 13803-15.
[6] Wu F, Shen SJ, Mo MY, et al. Cancinogenesis of DNP on Human Embro Nasopharyngeal Mucosa Transplants in Nude Mice[J]. Zhong Liu Fang Zhi Yan Jiu, 1995, 22(5): 278-80. [吴枫, 沈淑静, 莫梅英, 等. 二亚硝基哌嗪诱发移植于裸鼠的人胚鼻咽黏膜癌 变的研究[J]. 肿瘤防治研究, 1995, 22(5): 278-80.] [6] 吴枫, 沈淑静, 莫梅英, 等. 二亚硝基哌嗪诱发移植于裸鼠的人胚鼻咽黏膜癌变的研究[J]. 肿瘤防治研究, 1995, 22(5) : 278-80. Wu F, Shen SJ, Mo MY, et al. Cancinogenesis of DNP on Human Embro Nasopharyngeal Mucosa Transplants in Nude Mice[J]. Zhong Liu Fang Zhi Yan Jiu, 1995, 22(5) : 278-80.
[7] Li Y, Liu N, Huang D, et al. Proteomic analysis on N, N’- dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells[J]. BMC Biochem, 2012, 13: 25. [7] Li Y, Liu N, Huang D, et al. Proteomic analysis on N, N’- dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells[J]. BMC Biochem, 2012, 13: 25.
[8] Bi J, Guo AL, Lai YR, et al. Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays[J]. Neoplasma, 2010, 57(3): 191-7. [8] Bi J, Guo AL, Lai YR, et al. Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays[J]. Neoplasma, 2010, 57(3) : 191-7.
[9] Li Y, Zhang QL, Yang XL, et al. Clusterin is a potential serum marker of hepatic carcinoma[J]. Zhonghua Gan Zang Bing Za Zhi, 20 12, 20(4): 275-9. [李茵, 张钦乐, 杨小丽, 等. 肝癌中Clusterin 的质谱鉴定及验证[J]. 中华肝脏病杂志, 2012, 20(4): 275-9..] [9] 李茵, 张钦乐, 杨小丽, 等. 肝癌中Clusterin 的质谱鉴定及验证[J]. 中华肝脏病杂志, 2012, 20(4) : 275-9. Li Y, Zhang QL, Yang XL, et al. Clusterin is a potential serum marker of hepatic carcinoma[J]. Zhonghua Gan Zang Bing Za Zhi, 2012, 20(4) : 275-9.
[10] Xie D, Sham JS, Zeng WF, et al. Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression[J]. World J Gastroenterol, 2005, 11(21): 3285-9. [10] Xie D, Sham JS, Zeng WF, et al. Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression[J]. World J Gastroenterol, 2005, 11(21) : 3285-9.
[11] Wang X, Luo L, Dong D, et al. Clusterin plays an important role in clear renal cell cancer metastasis[J]. Urol Int, 2014, 92(2): 95-103. [11] Wang X, Luo L, Dong D, et al. Clusterin plays an important role in clear renal cell cancer metastasis[J]. Urol Int, 2014, 92(2) : 95-103.
[12] Cheng CY, Cherng SH, Wu WJ, et al. Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells[J]. Cancer Chemother Pharmacol, 2012, 69(1) : 145-54.
[12] Cheng CY, Cherng SH, Wu WJ, et al. Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells[J]. Cancer Chemother Pharmacol, 2012, 69(1): 14 5-54. [13] Fu Y, Lai Y, Liu J, et al. Lentivirus-mediated shrna interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells[J]. J Ovarian Res, 2015, 8: 59. [13] Fu Y, Lai Y, Liu J, et al. Lentivirus-mediated shrna interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells[J]. J Ovarian Res, 2015, 8: 59.
[14] Trougakos I P, Gonos E S. Clusterin/apolipoprotein J in human aging and cancer[J]. Int J Biochem Cell Biol, 2002, 34(11) : 1430-48.
[14] Trougakos I P, Gonos E S. Clusterin/apolipoprotein J in human aging and cancer[J]. Int J Biochem Cell Biol, 2002, 34(11): 14 30-48. [15] Fu Y, Lai Y, Wang Q, et al. Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer[J]. Mol Med Rep, 2013, 7(6) : 1726-32.
[15] Fu Y, Lai Y, Wang Q, et al. Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer[J]. Mol Med Rep, 2013, 7(6): 1726-32. [16] Frazzi R, Casali B, Iori M, et al. Increase in clusterin forms part of the stress response in Hodgkin’s lymphoma[J]. Int J Oncol, 2011, 38(3) : 677-84.
[16] Frazzi R, Casali B, Iori M, et al. Increase in clusterin forms part of the stress response in Hodgkin’s lymphoma[J]. Int J Oncol, 2011, 38 (3): 677-84. [17] Flanagan L, Whyte L, Chatterjee N, et al. Effects of clusterin over-expression on metastatic progression and therapy in breast cancer[J]. BMC Cancer, 2010, 10: 107.
[17] Flanagan L, Whyte L, Chatterjee N, et al. Effects of clusterin over-expression on metastatic progression and therapy in breast cancer[J]. BMC Cancer, 2010, 10: 107. [18] Henderson-Jackson EB, Nasir A, Chen DT, et al. Cytoplasmic clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage[J]. Pancreas, 2013, 42(6): 96 7-70. [18] Henderson-Jackson EB, Nasir A, Chen DT, et al. Cytoplasmic clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage[J]. Pancreas, 2013, 42(6) : 967-70.
[19] Rizzi F, Bettuzzi S. Clusterin (clu) and prostate cancer[J]. Adv Cancer Res, 2009, 105: 1-19.
[19] Rizzi F, Bettuzzi S. Clusterin (clu) and prostate cancer[J]. Adv Cancer Res, 2009, 105: 1-19. [20] Chou TY, Chen WC, Lee AC, et al. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the erk/slug pathway[J]. Cell Signal, 2009, 21(5) : 704-11.
[20] Chou TY, Chen WC, Lee AC, et al. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the erk/slug pathway[J]. Cell Signal, 2009, 21(5): 704-11. [21] Radziwon-Balicka A, Santos-Martinez MJ, Corbalan JJ, et al. Mechanisms of platelet-stimulated colon cancer invasion: Role of clusterin and thrombospondin 1 in regulation of theP38MAPKMMP- 9 pathway[J]. Carcinogenesis, 2014, 35(2) : 324-32.
[21] Radziwon-Balicka A, Santos-Martinez MJ, Corbalan JJ, et al. Mechanisms of platelet-stimulated colon cancer invasion: Role of clusterin and thrombospondin 1 in regulation of theP38MAPKMMP- 9 pathway[J]. Carcinogenesis, 2014, 35(2): 324-32. [22] Zhao XH, He HZ, Wang K. Glycosylation and localization of clusterin in esophageal squamous cell carcinoma[J]. Di Er Jun Yi Da Xue Xue Bao, 2005, 26(12): 1333-6. [赵晓航, 何洪智, 王堃. 食管鳞癌中clusterin的糖基化修饰和表达定位改变[J]. 第二军 医大学学报, 2005, 26(12): 1333-6.] [22] 赵晓航, 何洪智, 王堃. 食管鳞癌中clusterin的糖基化修饰和表达定位改变[J]. 第二军医大学学报, 2005, 26(12) : 1333-6. Zhao XH, He HZ, Wang K. Glycosylation and localization of clusterin in esophageal squamous cell carcinoma[J]. Di Er Jun Yi Da Xue Xue Bao, 2005, 26(12) : 1333-6.
[23] Tian XF, Wang HM. Expression and significance of clusterin and its relation to ki-67 in larynx squamous caracinoma[J]. Zhongguo Xian Dai Yi Xue Za Zhi, 2009, 19(2): 177-80. [田秀芬, 王慧敏. Clusterin在喉鳞状细胞癌中的表达及其与ki-67的关系[J]. 中国 现代医学杂志, 2009, 19(2): 177-80.] [23] 田秀芬, 王慧敏. Clusterin在喉鳞状细胞癌中的表达及其与ki-67的关系[J]. 中国现代医学杂志, 2009, 19(2) : 177-80. Tian XF, Wang HM. Expression and significance of clusterin and its relation to ki-67 in larynx squamous caracinoma[J]. Zhongguo Xian Dai Yi Xue Za Zhi, 2009, 19(2) : 177-80.
[24] Redondo M, Rodrigo I, Alcaide J, et al. Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas[J]. Histopathology, 2010, 56(7): 932-6. [24] Redondo M, Rodrigo I, Alcaide J, et al. Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas[J]. Histopathology, 2010, 56(7) : 932-6.
[25] Pucci S, Bonanno E, Sesti F, et al. Clusterin in stool: A new biomarker for colon cancer screening?[J]. Am J Gastroenterol, 2009, 104(11) : 2807-15.
[25] Pucci S, Bonanno E, Sesti F, et al. Clusterin in stool: A new biomarker for colon cancer screening?[J]. Am J Gastroenterol, 20 09, 104(11): 2807-15.
下载:
计量
- 文章访问数: 1429
- HTML全文浏览量: 279
- PDF下载量: 514
